This collaboration will offer non-stress tests by INVU, within Babyscripts' commercial ecosystem, with the goal of advancing pregnancy care delivery.
Clinically validated, the program improves health engagement with new and expecting moms on behalf of health organizations and government entities.
Babyscripts monitors expectant mothers throughout pregnancy and sends pertinent health information to soon-to-be mothers and their physicians.
The Clearblue Connected Ovulation adapts and tracks the user's personal hormone profile and can typically identify four or more best days to get pregnant.
The device uses an advanced algorithm to detect the body's internal signals to provide women with information on ovulation, menstruation, sleep and stress.
A Medicaid member was estimated to be 76% more likely to have a 6-month or more prenatal visit if she was the WYhealth Due Date Plus app user.
The study has shown correlation between pulse rate and identification of a woman's fertile window; the company also announced new updates for its mobile app.
The study will use WebMD's newly redesigned Pregnancy app for iPhone, enabling participants to easily answer questions and share connected device data.
The app has been certified by the UK's Medicines and Healthcare products Regulatory Agency, which appointed Germany-based Tüv Süd to perform the inspection.
The iOS app allows users to track period of their cycle, including flow, symptoms, activities, and moods. Also, tracking is available for birth control.